The DOI matches its Crossref record; 280 of the 280 references it cites were found in a registry or an index.
Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases
Open accessAbstract
Glycogen synthase kinase‐3 (GSK3) is a highly evolutionarily conserved serine/threonine protein kinase first identified as an enzyme that regulates glycogen synthase (GS) in response to insulin stimulation, which involves GSK3 regulation of glucose metabolism and energy homeostasis. Both isoforms of GSK3, GSK3α, and GSK3β, have been implicated in many biological and pathophysiological processes. The various functions of GSK3 are indicated by its widespread distribution in multiple cell types and tissues. The studies of GSK3 activity using animal models and the observed effects of GSK3‐specific inhibitors provide more insights into the roles of GSK3 in regulating energy metabolism and homeostasis. The cross‐talk between GSK3 and some important energy regulators and sensors and the regulation of GSK3 in mitochondrial activity and component function further highlight the molecular mechanisms in which GSK3 is involved to regulate the metabolic activity, beyond its classical regulatory effect on GS. In this review, we summarize the specific roles of GSK3 in energy metabolism regulation in tissues that are tightly associated with energy metabolism and the functions of GSK3 in the development of metabolic disorders. We also address the impacts of GSK3 on the regulation of mitochondrial function, activity and associated metabolic regulation. The application of GSK3 inhibitors in clinical tests will be highlighted too. Interactions between GSK3 and important energy regulators and GSK3‐mediated responses to different stresses that are related to metabolism are described to provide a brief overview of previously less‐appreciated biological functions of GSK3 in energy metabolism and associated diseases through its regulation of GS and other functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–280 of 280
Meares, G. P., Mines, M. A., Beurel, E., Eom, T.-Y., Song, L., Zmijewska, A. A., & Jope, R. S. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.02.012 · Cited by 79
Regulation of ER stress-induced autophagy by GSK3β-TIP60-ULK1 pathway
Nie, T., Yang, S., Ma, H., Zhang, L., Lu, F., Tao, K. X., Wang, R., Yang, R., Huang, L. H., Mao, Z., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.423 · Cited by 79
Roh, M., Eom, T.-Y., Zmijewska, A. A., Sarno, P. D., Roth, K. A., & Jope, R. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.039 · Cited by 78
Ohori, K., Miura, T., Tanno, M., Miki, T., Sato, T., Ishikawa, S., Horio, Y., & Shimamoto, K. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00092.2008 · Cited by 76
Multiple Roles for Glycogen Synthase Kinase-3 as a Drug Target in Alzheimers Disease
Huang, H., & Klein, P. S. (2006) · Current Drug Targets · doi:10.2174/1389450110607011389 · Cited by 76
Yang, F., Wu, R., Jiang, Z., Chen, J., Nan, J., Su, S., Zhang, N., Wang, C., Zhao, J., Ni, C., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0579-9 · Cited by 76
van der Velden, J. L. J., Schols, A. M. W. J., Willems, J., KELDERS, M. C. J. M., & LANGEN, R. C. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707812200 · Cited by 75
Maqbool, M., & Hoda, N. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170714141450 · Cited by 75
GSK3-mediated raptor phosphorylation supports amino-acid-dependent mTORC1-directed signalling
Stretton, C., Hoffmann, T. M., Munson, M. J., Prescott, A. R., Taylor, P. M., Ganley, I. G., & Hundal, H. S. (2015) · Biochemical Journal · doi:10.1042/bj20150404 · Cited by 74
Inhibition of GSK-3 Induces Differentiation and Impaired Glucose Metabolism in Renal Cancer
Pal, K., Cao, Y., Gaisina, I. N., Bhattacharya, S., Dutta, S. K., Wang, E., Gunosewoyo, H., Kozikowski, A. P., Billadeau, D. D., & Mukhopadhyay, D. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0681 · Cited by 73
Abnormalities in glucose regulation associated with mental illness and treatment
Haupt, D. W., & Newcomer, J. W. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00471-3 · Cited by 72
Benzler, J., Ganjam, G. K., Krüger, M., Pinkenburg, O., Kutschke, M., Stöhr, S., Steger, J., Koch, C. E., Oelkrug, R., Schwartz, M. W., et al. (2012) · Biochemical Journal · doi:10.1042/bj20120834 · Cited by 72
Zhou, W., Wang, L., Gou, S., Wang, T., Zhang, M., Liu, T., & Wang, C. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.10.033 · Cited by 71
Self-citationGSK-3 and mitochondria in cancer cells
Chiara, F., & Rasola, A. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00016 · Cited by 71
Bhattacharjee, R., Goswami, S., Dudiki, T., Popkie, A. P., Phiel, C. J., Kline, D., & Vijayaraghavan, S. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.114.124495 · Cited by 70
Zhou, J., Lal, H., Chen, X., Shang, X., Song, J., Li, Y., Kerkelä, R., Doble, B. W., MacAulay, K., DeCaul, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41407 · Cited by 69
Lal, H., Zhou, J., Ahmad, F., Zaka, R., Vagnozzi, R. J., DeCaul, M., Woodgett, J. R., Gao, E., & Force, T. L. (2011) · Circulation · doi:10.1161/circulationaha.111.050666 · Cited by 68
Muscle-specific GSK-3β ablation accelerates regeneration of disuse-atrophied skeletal muscle
Pansters, N. A. M., Schols, A. M. W. J., Verhees, K. J. P., de Theije, C. C., Snepvangers, F. J. M., KELDERS, M. C. J. M., Ubags, N. D. J., Haegens, A., & LANGEN, R. C. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.006 · Cited by 67
Byun, H.-O., Jung, H.-J., Seo, Y.-H., Lee, Y.-K., Hwang, S.-C., Seong Hwang, E., & Yoon, G. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.04.012 · Cited by 66
McCamphill, P. K., Stoppel, L. J., Senter, R. K., Lewis, M. C., Heynen, A. J., Stoppel, D. C., Sridhar, V., Collins, K. A., Shi, X., Pan, J. Q., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aam8572 · Cited by 64
Lappas, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115854 · Cited by 63
MacAulay, K., Hajduch, É., Blair, A. S., Coghlan, M. P., Smith, S. A., & Hundal, H. S. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03777.x · Cited by 63
Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma
Cervello, M., Augello, G., Cusimano, A., Emma, M. R., Balasus, D., Azzolina, A., McCubrey, J. A., & Montalto, G. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.06.002 · Cited by 61
Anmella, G., Fico, G., Lotfaliany, M., Hidalgo‐Mazzei, D., Soto-Angona, Ó., Giménez‐Palomo, A., Amoretti, S., Murru, A., Raduà, J., Solanes, A., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.03.034 · Cited by 60
Azoulay‐Alfaguter, I., Yaffe, Y., Licht-Murava, A., Urbańska, M., Jaworski, J., Pietrokovski, S., Hirschberg, K., & Eldar-Finkelman, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127969 · Cited by 59
Pansters, N., van der Velden, J. L. J., KELDERS, M. C. J. M., Laeremans, H., Schols, A. M. W. J., & LANGEN, R. C. J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0467-7 · Cited by 58
Unregulated mitochondrial GSK3β activity results in NADH:Ubiquinone oxidoreductase deficiency
King, T. D., Clodfelder‐Miller, B., Barksdale, K. A., & Bijur, G. N. (2008) · Neurotoxicity Research · doi:10.1007/bf03033861 · Cited by 57
McAlpine, C. S., Bowes, A. J., Khan, M. I., Shi, Y., & Werstuck, G. H. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.237941 · Cited by 57
Benzler, J., Andrews, Z. B., Pracht, C., Stöhr, S., Shepherd, P. R., Grattan, D. R., & Tups, A. (2013) · Endocrinology · doi:10.1210/en.2013-1746 · Cited by 56
Zaragosi, L., Wdziekonski, B., Fontaine, C., Villageois, P., Peraldi, P., & Dani, C. (2008) · BMC Cell Biology · doi:10.1186/1471-2121-9-11 · Cited by 55
Targeting glycogen synthase kinase-3 in insulin signalling
Frame, S., & Zheleva, D. I. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.3.429 · Cited by 55
Beurel, E., & Jope, R. S. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.02.019 · Cited by 55
Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015)
Palomo, V., & Martínez, A. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1259412 · Cited by 55
SIRT2 deacetylase regulates the activity of GSK3 isoforms independent of inhibitory phosphorylation
Sarikhani, M., Mishra, S., Maity, S., Kotyada, C., Wolfgeher, D. J., Gupta, M. P., Singh, M., & Sundaresan, N. R. (2018) · eLife · doi:10.7554/elife.32952 · Cited by 55
The protease Omi regulates mitochondrial biogenesis through the GSK3β/PGC-1α pathway
Xu, R., Hu, Q., Ma, Q., Liu, C., & Wang, G. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.328 · Cited by 54
PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome
Chen, H., Fajol, A., Hoene, M., Zhang, B., Schleicher, E. D., Lin, Y., Calaminus, C., Pichler, B. J., Weigert, C., Häring, H. U., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601355113 · Cited by 54
Chen, L., Ren, F. Z., Zhang, H., Wen, T., Piao, Z.-F., Zhou, L., Zheng, S., Zhang, J., Chen, Y., Han, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045202 · Cited by 53
Jiang, J., Fan, Y., Zhang, W., Shen, Y., Liu, T., Yao, M., Gu, J., Tu, H., & Gan, Y. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.27420 · Cited by 53
Tissue-specific expression and regulation of GSK-3 in human skeletal muscle and adipose tissue
Ciaraldi, T. P., Oh, D. K., Christiansen, L., Nikoulina, S. E., Kong, A. P. S., Baxi, S. C., Mudaliar, S. R. D., & Henry, R. R. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00176.2006 · Cited by 52
Structure-based optimization of oxadiazole-based GSK-3 inhibitors
Monte, F. L., Kramer, T., Gu, J., Brodrecht, M., Pilakowski, J., Fuertes, A., Domínguez, J. M., Plotkin, B., Eldar-Finkelman, H., & Schmidt, B. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.06.006 · Cited by 52
Col, J. D., & Dolcetti, R. (2008) · Cell Cycle · doi:10.4161/cc.7.18.6733 · Cited by 51
Wang, L., Wang, Y., Zhang, C., Li, J., Meng, Y., Dou, M., Noguchi, C. T., & Di, L. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311363 · Cited by 51
Self-citationGSK3β Is Involved in the Relief of Mitochondria Pausing in a Tau-Dependent Manner
Llorens-Martín, M., López‐Doménech, G., Soriano, E., & Ávila, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027686 · Cited by 50
Goldbart, A. D., Cheng, Z. J., Brittian, K. R., & Gozal, D. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.004 · Cited by 50
Theeuwes, W. F., Gosker, H. R., LANGEN, R. C. J., Pansters, N., Schols, A. M. W. J., & Remels, A. H. V. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.06.002 · Cited by 50
Wnt/β-Catenin Mediates AICAR Effect to Increase GATA3 Expression and Inhibit Adipogenesis
Wang, L., & Di, L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.641332 · Cited by 48
Self-citationOmar, M. A., Wang, L., & Clanachan, A. S. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvp421 · Cited by 47
Self-citationMaurin, H., Lechat, B., Dewachter, I., Ris, L., Louis, J. V., Borghgraef, P., Devijver, H., Jaworski, T., & LEUVEN, F. V. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-27 · Cited by 45
Patel, S., MacAulay, K., & Woodgett, J. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015845 · Cited by 44
Schnitzer, S. E., Schmid, T., Zhou, J., Eisenbrand, G., & Brüne, B. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.12.023 · Cited by 44
Roles of GSK3 in metabolic shift toward abnormal anabolism in cell senescence
Kim, Y., Seo, Y., Park, C., Yoon, S., & Yoon, G. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05617.x · Cited by 44
LiCl regulates mitochondrial biogenesis during megakaryocyte development
Undi, R. B., Gutti, U., & Gutti, R. K. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.10.003 · Cited by 43
Tka, K. H. A., Mahfoudh-Boussaid, A., Zaoualí, M. A., Kammoun, R., Béjaoui, M., Ghoul, S., Roselló‐Catafau, J., & Abdennebi, H. B. (2015) · Analytical Cellular Pathology · doi:10.1155/2015/635172 · Cited by 42
Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2016–2019)
Roca, C., & Campillo, N. E. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2020.1815706 · Cited by 42
Role of Glycogen Synthase Kinase-3α in Insulin Action in Cultured Human Skeletal Muscle Cells
Ciaraldi, T. P., Nikoulina, S. E., Bandukwala, R., Carter, L., & Henry, R. R. (2007) · Endocrinology · doi:10.1210/en.2006-0932 · Cited by 41
Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase‐3β activation
Zhang, Y.-J., Xu, Y., Liu, Y., Yin, J., & Wang, J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.095 · Cited by 41
Isoform-specific requirement for GSK3α in sperm for male fertility†
Bhattacharjee, R., Goswami, S., Dey, S., Gangoda, M. E., Brothag, C., Eisa, A. A., Woodgett, J. R., Phiel, C. J., Kline, D., & Vijayaraghavan, S. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy020 · Cited by 41
Guidotti, S., Minguzzi, M., Platano, D., Cattini, L., Trisolino, G., Mariani, E., & Borzı̀, R. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143865 · Cited by 40
Identification of a novel selective and potent inhibitor of glycogen synthase kinase-3
Noori, M. S., Bhatt, P. M., Courreges, M. C., Ghazanfari, D., Cuckler, C. M., Orac, C. M., McMills, M. C., Schwartz, F., Deosarkar, S. P., Bergmeier, S. C., et al. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00061.2019 · Cited by 40
GSK3β is a key regulator of the ROS-dependent necrotic death induced by the quinone DMNQ
Ciotti, S., Iuliano, L., Cefalù, S., Comelli, M., Mavelli, I., Giorgio, E. D., & Brancolini, C. (2020) · Cell Death and Disease · doi:10.1038/s41419-019-2202-0 · Cited by 40
Ning, K., Miller, L. C., Laidlaw, H. A., Watterson, K. R., Gallagher, J. R., Sutherland, C. D., & Ashford, M. L. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806774200 · Cited by 39
Guidotti, S., Minguzzi, M., Platano, D., Santi, S., Trisolino, G., Filardo, G., Mariani, E., & Borzı̀, R. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-12129-5 · Cited by 39
Liu, W., Wang, H., Wang, Y., Li, H., & Liu, J. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.102 · Cited by 37
Sunaga, D., Tanno, M., Kuno, A., Ishikawa, S., Ogasawara, M., Yano, T., Miki, T., & Miura, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112529 · Cited by 37
Ogawa, F., Murphy, L. C., Malavasi, E. L. V., O’Sullivan, S. T., Torrance, H. S., Porteous, D. J., & Millar, J. K. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00255 · Cited by 36
Motawi, T. K., Bustanji, Y. K., El‐Maraghy, S. A., Taha, M. O., & Al-Ghussein, M. A. S. (2013) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21503 · Cited by 34
Activation of GSK3β by Sirt2 Is Required for Early Lineage Commitment of Mouse Embryonic Stem Cell
Si, X., Chen, W., Guo, X., Chen, L., Wang, G., Xu, Y., & Kang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076699 · Cited by 34
GSK3 is a negative regulator of the thermogenic program in brown adipocytes
Markussen, L. K., Winther, S., Wicksteed, B. L., & Hansen, J. B. (2018) · Scientific Reports · doi:10.1038/s41598-018-21795-y · Cited by 32
Park, S. Y., Lee, Y., Lee, W. S., Park, O. J., & Kim, Y.-M. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-109 · Cited by 31
GSK3‐activated STAT5 regulates expression of SFRPs to modulate adipogenesis
Wang, L., Wang, Y., Meng, Y., Zhang, C., & Di, L. (2018) · The FASEB Journal · doi:10.1096/fj.201701314r · Cited by 31
Self-citationMa, Z., Zhong, Z., Zheng, Z., Shi, X., & Zhang, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105528 · Cited by 30
Vadrot, N., Ghanem, S., Braut‐Boucher, F., Gavrilescu, L., Pilard, N., Mansouri, A., Moreau, R., & Reyl-Desmars, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040879 · Cited by 27
Verhees, K. J. P., Pansters, N. A. M., Baarsma, H. A., Remels, A. H. V., Haegens, A., de Theije, C. C., Schols, A. M. W. J., Gosens, R., & LANGEN, R. C. J. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-117 · Cited by 27
Gupte, M., Tumuluru, S., Sui, J. Y., Singh, A. P., Umbarkar, P., Parikh, S. S., Ahmad, F., Zhang, Q., Force, T. L., & Lal, H. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.01.013 · Cited by 26
AMPK regulates KATP channel trafficking via PTEN inhibition in leptin-treated pancreatic β-cells
Park, S.-H., Ho, W., & Jeon, J. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.09.099 · Cited by 23
The Obesity–Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients
Sfera, A., Osorio, C. P., Inderias, L., Parker, V., Price, A. I., & Cummings, M. A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00020 · Cited by 19
Flepisi, B. T., Lochner, A., & Huisamen, B. (2013) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-013-6467-8 · Cited by 16
Gupte, M., Umbarkar, P., Singh, A. P., Zhang, Q., Tousif, S., & Lal, H. (2020) · Cells · doi:10.3390/cells9051120 · Cited by 15
Exploiting Substrate Recognition for Selective Inhibition of Protein Kinases
Licht-Murava, A., & Eldar-Finkelman, H. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800672741 · Cited by 12
Ueda, M., Stefan, T., Stetson, L. C., Ignatz-Hoover, J. J., Tomlinson, B. K., Creger, R. J., Cooper, B., Lazarus, H. M., Lima, M. J. G. D., Wald, D. N., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00327 · Cited by 12
Cited by
Wu, X., Yang, Z., Zou, J., Gao, H., Shao, Z., Li, C., & Lei, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02179-x · Cited by 88
Metadata
- Authors
- Wang, L., Li, J., & Di, L.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2021-11-03
- Volume
- 42
- Issue
- 2
- Pages
- 946-982
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W3211091011
- Cited by
- 261
- References
- 280
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.